NCT07669142Active, not recruiting
EFFECTS OF TELENURSING IN PREDIALYSIS PATIENTS
THE EFFECT OF TELE-NURSING PRACTICES ON QUALITY OF LIFE AND CLINICAL OUTCOMES IN PATIENTS WITH PREDIALYSIS CHRONIC KIDNEY DISEASE
Source: ClinicalTrials.gov · Last updated 25 Jun 2026
Brief summary (registry, in English)
This study aims to evaluate the effect of tele-nursing practices on quality of life and clinical outcomes in predialysis patients with chronic kidney disease. The study will be conducted with patients diagnosed with stage 3A, 3B, or 4 chronic kidney disease who are followed in a nephrology outpatient clinic. Participants will be assigned to intervention and control groups. Patients in the intervention group will receive a structured tele-nursing program including patient education, telephone or online follow-up, reminders, and counseling for disease management. Patients in the control group will continue to receive routine outpatient care. Quality of life, medication adherence, self-care management, blood pressure, body weight, edema status, and laboratory parameters such as eGFR, creatinine, blood urea nitrogen, potassium, phosphorus, calcium, albumin, hemoglobin, and bicarbonate will be evaluated at baseline, 3 months, and 6 months. The study is expected to show whether tele-nursing support can improve quality of life, self-care behaviors, treatment adherence, and clinical outcomes in predialysis patients.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 66 (actual)
- First submitted
- 15 Jun 2026
- Start date
- 15 May 2026
- Primary completion date
- 15 Jan 2027
- Lead sponsor
- Istanbul University - Cerrahpasa
- Diseases
- Chronic kidney disease
- NCT number
- NCT07669142
What you commit to
- Study type: Interventional
- Participants enrolled: 66
- From 15 May 2026 to the primary completion date, 15 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having stage 1,2 and 5 chronic kidney disease Receiving hemodialysis or peritoneal dialysis treatment Having a history of acute kidney injury within the last 3 months Having a terminal illness Having severe cognitive impairment, psychiatric disorder, or communication problem that prevents participation in the study Having hearing, speech, or visual impairment that prevents effective tele-nursing communication Not having access to the required communication tools for remote follow-up Participating in another interventional study that may affect the outcomes of this research Refusing to participate in the study Withdrawing informed consent during the study period
Who the study is looking for
- Being 18 years of age or older Having a diagnosis of stage 3A, 3B, or 4 chronic kidney disease Having an estimated glomerular filtration rate between 15 and 59 mL/min/1.73 m² Being followed in the nephrology outpatient clinic for at least 3 months Not receiving dialysis treatment Being able to communicate in Turkish Having access to a telephone or smart device suitable for tele-nursing follow-up Being able to participate in telephone, messaging, or online follow-up Voluntarily agreeing to participate in the study Providing informed consent
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Samsun City Hospital, Samsun, 55000, Türkiye (Turkey) Coordinator of this site? Confirm its status | Samsun | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.